Daxor Corporation

Rentabilité sur six mois: +17.29%
Rendement en dividendes: 0%
Secteur: Healthcare

8.75 $

0 $ 0%
7.05 $
9.89 $

paper.min_max_per_year

Calendrier des promotions Daxor Corporation

Paramètres de base

IPO date
1992-03-17
ISIN
US2394671034
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
1.31
Дивиденд ао
0.06
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 17.34 1
P/BV 1.03 9
P/E 68.89 1
Efficacité
Nom Signification Grade
ROA 1.5 1
ROE 1.54 1
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0.6429 6.43
Croissance moyenne du dividende -29.17 0
Devoir
Nom Signification Grade
Debt/EBITDA 2.29 6
Debt/Ratio 0.0206 10
Debt/Equity 0.0235 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % -313.95 0
Rentabilité Ebitda, % -166.48 0
Rentabilité EPS, % -125.56 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 8.75 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 8.75 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 7.74 $ 0 $ 0 $ +13.05 % 0 % 0 %
common.calendar.number_days.90d 8.05 $ 7.2 $ 9.29 $ +8.74 % 0 % 0 %
common.calendar.number_days.180d 7.46 $ 7.05 $ 9.29 $ +17.29 % 0 % 0 %
common.calendar.number_days.1y 8 $ 7.05 $ 9.89 $ +9.38 % 0 % 0 %
common.calendar.number_days.3y 12.9 $ 7.05 $ 14.23 $ -32.17 % 0 % 0 %
common.calendar.number_days.5y 19.39 $ 7.05 $ 18.95 $ -54.87 % 0 % 0 %
common.calendar.number_days.10y 3.52 $ 3.52 $ 23.78 $ +248.47 % 0 % 0 %
common.calendar.number_days.ytd 8.09 $ 7.05 $ 9.29 $ +8.11 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Michael Richard Feldschuh Chairman, President & CEO 100k 1969 (56 années)
Mr. Jonathan Adam Feldschuh Chief Scientific Officer & Director 127.92k 1965 (60 années)
Mr. Robert J. Michel CPA, CPA, M.B.A. CFO, Chief Compliance Officer & Corporate Secretary N/A 1957 (68 années)
Ms. Linda Cooper Vice President of Development & Operations N/A
Ms. Kathryn A. Kornafel Senior VP of Marketing & Commercial Development N/A
Mr. Guido Manzo Vice President of Sales N/A
Ms. Jean Oertel Senior Vice President Commercialization & Customer Experience N/A
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. Chief Medical Officer

Informations sur l'entreprise

Adresse: United States, Oak Ridge. TN, 109 Meco Lane - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.daxor.com

À propos de l'entreprise Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.